<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04183374</url>
  </required_header>
  <id_info>
    <org_study_id>DFI2019Skiveintervention</org_study_id>
    <nct_id>NCT04183374</nct_id>
  </id_info>
  <brief_title>DNA Damage and Subfertility in Males - Lifestyle Interventions to Improve Male Fertility and Health</brief_title>
  <acronym>ReproDNA</acronym>
  <official_title>DNA Damage and Subfertility in Males - Lifestyle Interventions to Improve Male Fertility and Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regionshospitalet Viborg, Skive</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A lifestyle intervention study in infertile males of couples seeking fertility treatment with
      a DNA fragmentation index (DFI) above 15 percentage. A reduction in DNA fragmentation index
      of 10 percentage points is expected after 3-4 months of intervention.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in DNA fragmentation index (DFI)</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>DFI is measured by SCSA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in classical sperm parameters</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Sperm count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in classical sperm parameters</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Sperm motility (movement)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in classical sperm parameters</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Sperm morphology (structure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in classical sperm parameters</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Sperm concentration in mio sperm pr. milliliter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in parameters for metabolic syndrome</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in parameters for metabolic syndrome</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Blood pressure in millimeters of mercury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in parameters for metabolic syndrome</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Hemoglobin A1c in mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in parameters for metabolic syndrome</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Body mass index in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma lipids</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>Plasma lipids i.e. Total cholesterol, high density lipoprotein, low density lipoprotein and triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum D-vitamin levels</measure>
    <time_frame>3-4 months after inclusion</time_frame>
    <description>25-hydroxy vitamin D (D3+D2) measured as nmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants achieving live birth</measure>
    <time_frame>Week 30-42 of pregnancy</time_frame>
    <description>Birth of a living child after week 23. Registered through self-reported schemes sent to the clinic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with clinical pregnancy</measure>
    <time_frame>Week 7-8 of pregnancy</time_frame>
    <description>Measurement of heart beat by ultrasound scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with biochemical pregnancy</measure>
    <time_frame>Day 14-17 of pregnancy</time_frame>
    <description>Increase in serum hCG levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative live birth rate</measure>
    <time_frame>9-24 months after inclusion</time_frame>
    <description>Live births originating from one controlled stimulation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">680</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lifestyle intervention i.e. diet, exercise, smoking cessation, alcohol limitations, dietary supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Life style</intervention_name>
    <description>Lifestyle intervention i.e. diet, exercise, smoking cessation, alcohol limitations, dietary supplementation</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DNA fragmentation index above 15 %

        Exclusion Criteria:

          -  TESA/PESA
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fertility Clinic Skive, Skive Regional Hospital</name>
      <address>
        <city>Skive</city>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Humaidan, DMSc</last_name>
      <phone>+4578445760</phone>
      <email>fertilitetsklinikken@midt.rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>November 28, 2019</last_update_submitted>
  <last_update_submitted_qc>November 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Peter Humaidan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>male infertility</keyword>
  <keyword>DNA fragmentation Index</keyword>
  <keyword>DFI</keyword>
  <keyword>life style intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

